Journal of Jilin University(Medicine Edition) ›› 2021, Vol. 47 ›› Issue (2): 275-283.doi: 10.13481/j.1671-587X.20210204
• Research in basic medicine • Previous Articles Next Articles
Bingxue QI1,Yan MA1,Yixian ZHANG2,Yadong SUN1(
),Lining MIAO2
Received:2020-09-08
Online:2021-03-28
Published:2021-03-25
Contact:
Yadong SUN
E-mail:ydsun_2005@163.com
CLC Number:
Bingxue QI,Yan MA,Yixian ZHANG,Yadong SUN,Lining MIAO. Effect of liraglutide on expressions of mRNA and protein of related proteins after podocyte injury induced by high glucose and its mechanism[J].Journal of Jilin University(Medicine Edition), 2021, 47(2): 275-283.
| 1 | ZAVATTARO M, CAPUTO M, SAMA M T, et al. One-year treatment with liraglutide improved renal function in patients with type 2 diabetes: a pilot prospective study[J]. Endocrine, 2015, 50(3):620-626. |
| 2 | DE LUCAS M D G, BUENO B A, SIERRA J O. Liraglutide preserves renal function in overweight diabetic patients with stage 3 chronic kidney disease[J]. Euro J Int Med,2017, 44:e28-e29. |
| 3 | KRISTENSEN S L, RØRTH R, JHUND P S, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials[J]. Lancet Diabetes Endocrinol, 2019, 7(10):776-785. |
| 4 | KAWANAMI D, TAKASHI Y. GLP-1 receptor agonists in diabetic kidney disease: from clinical outcomes to mechanisms[J]. Front Pharmacol, 2020, 11:967. |
| 5 | ZHANG S S, WU Z, ZHANG Z,et al. Glucagon-like peptide-1 inhibits the receptor for advanced glycation endproducts to prevent podocyte apoptosis induced by advanced oxidative protein products[J]. Biochem Biophys Res Commun, 2017, 482(4):1413-1419. |
| 6 | SHI J X, HUANG Q. Glucagonlike peptide1 protects mouse podocytes against high glucoseinduced apoptosis, and suppresses reactive oxygen species production and proinflammatory cytokine secretion,through sirtuin 1 activation in vitro[J]. Mol Med Rep, 2018, 18(2): 1789-1797. |
| 7 | CHEN P, SHI X Z,XU X, et al. Liraglutide ameliorates early renal injury by the activation of renal FoxO1 in a type 2 diabetic kidney disease rat model[J]. Diabetes Res Clin Pract, 2018, 137:173-182. |
| 8 | SIDDIQI F S, MAJUMDER S, THAI K, et al. The histone methyltransferase enzyme enhancer of zeste homolog 2 protects against podocyte oxidative stress and renal injury in diabetes[J]. J Am Soc Nephrol, 2016,27(7):2021-2034. |
| 9 | CARNEY E F. Cholesterol and podocyte injury[J]. Nat Rev Nephrol, 2013, 9(9):493-493. |
| 10 | TANG S C W, YIU W H. Innate immunity in diabetic kidney disease[J]. Nat Rev Nephrol, 2020,16(4):206-222. |
| 11 | HARALOSSON B,NYSTROÖM J,DEEN W M. Properties of the glomerular barrier and mechanisms of proteinuria[ J ]. Physiol Rev, 2008, 88(2):451-487. |
| 12 | SCHIFFER T A, FRIEDERICH-PERSSON M. Mitochondrial reactive oxygen species and kidney hypoxia in the development of diabetic nephropathy[J]. Front Physiol, 2017, 8:211. |
| 13 | UMANATH K, LEWIS J B. Update on diabetic nephropathy: core curriculum 2018[ J ]. Am J Kidney Dis, 2018, 71(6):884-895. |
| 14 | LI X, CHUANG PY, D’AGATI V D, et al. Nephrin preserves podocyte viability and glomerular structure and function in adult kidneys[J]. J Am Soc Nephrol, 2015, 26(10):2361-2377. |
| 15 | SAGAR A, ARIF E, SOLANKI A K, et al. Targeting Neph1 and ZO-1 protein-protein interaction in podocytes prevents podocyte injury and preserves glomerular filtration function[J]. Sci Rep, 2017, 7(1):12047. |
| 16 | KOSTOVSKA I, TOSHESKA-TRAJKOVSKA K, LABUDOVIK D, et al. Nephrin and podocalyxin-markers for early detection of hypertensive nephropathy [J]. Atherosclerosis Suppl, 2018, 32:132. |
| 17 | PONCHIARDI C, MAUER M, NAJAFIAN B. Temporal profile of diabetic nephropathy pathologic changes[J]. Curr Diab Rep, 2013, 13:592-599. |
| 18 | IMASAWA T, OBRE E, BELLANCE N, et al. High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy[J]. Faseb J, 2017, 31(1):294-307. |
| 19 | WEIL E J, LEMLEY K V, MASON C C, et al. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy[J]. Kidney Int, 2012, 82(9):1010-1017. |
| 20 | SHARMA R, MCDONALD T S, ENG H, et al. In vitro metabolism of the glucagon-like peptide-1 (GLP-1)-derived metabolites GLP-1(9-36)amide and GLP-1(28-36)amide in mouse and human hepatocytes[J]. Drug Metab Dispos, 2013,41(12):2148-2157. |
| 21 | MANN J F E, ORSTED D D, BUSE J B, et al. Liraglutide and renal outcomes in type 2 diabetes[J]. New Engl J Med, 2017, 377(22):2197-2198. |
| 22 | YIN W, JIANG Y, XU S, et al. Protein kinase C and protein kinase A are involved in the protection of recombinant human glucagon‐like peptide‐1 on glomeruli and tubules in diabetic rats[J]. J Diabetes Investig, 2019, 10:613-625. |
| 23 | LILJEDAHL L, PEDERSEN M H, MCGUIRE J N, et al. The impact of the glucagon-like peptide 1 receptor agonist liraglutide on the streptozotocin-induced diabetic mouse kidney proteome[J]. Physiol Rep, 2019, 7(4):e13994. |
| 24 | LI Y K, MA D X, WANG Z M, et al. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis[J]. Pharmacol Res, 2018, 131:102-111. |
| 25 | JIA Y, ZHENG Z J,GUAN M P,et al. Exendin-4 ameliorates high-glucose-induced fibrosis by inhibiting the secretion of miR-192 from injured renal tubular epithelial cells[J]. Exp Mol Med, 2018, 50(5):1-13. |
| 26 | MUSKIET M H A, TONNEIJCK L, SMITS M M, et al. GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes[J]. Nat Rev Nephrol, 2017, 13(4):605-628. |
| 27 | REN Q, YOU YU S. CD2-associated protein participates in podocyte apoptosis via PI3K/Akt signaling pathway[J]. J Recept Signal Transduct Res, 2016, 36(3):288-291. |
| 28 | WANG Y Y, TANG L Q, WEI W. Berberine attenuates podocytes injury caused by exosomes derived from high glucose-induced mesangial cells through TGFβ1-PI3K/AKT pathway[J]. Eur J Pharmacol, 2018, 824:185-192. |
| 29 | 谢海平,林 帆,陈 彦,等利拉鲁肽治疗2型糖尿病合并非酒精性脂肪性肝病的研究进展[J].临床肝胆病杂志,2020,36(9):2111-2114. |
| 30 | 李德伦,吴玲玲,董哲毅,等.小檗碱治疗肾脏疾病研究现状[J].解放军医学杂志,2020,45(10):1092-1098. |
| [1] | Yang LI,Shiyang LI,Hongmei ZHANG,Qianqian LIU,Yubing CHEN. Effect of NGFR gene expression differences on promotion of apoptosis of squamous cell carcinoma and adenocarcinoma cells by PD-1 inhibitor-activated T lymphocytes [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 680-693. |
| [2] | Qiaotong REN,Weihua WU,Xingxiang WANG,Shichao WANG,Yipeng CHENG,Chun LI. Effect of interleukin-17 recepter B gene silencing on proliferation, invasion and apoptosis of lung adenocarcinoma A549 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 738-745. |
| [3] | Qiuping SU,Lei XING,Wei ZHANG,Shan JIANG,Yangyang ZHAO,Fangfang CHEN. Research progress in anti-tumor mechanism of berberine and application of its novel nano-delivery system in tumor therapy [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 863-871. |
| [4] | Jie YU,Zongkang WANG,Xun LIU,Yanan YANG,Jin TAN. Effect of miR-153-3p/PGC-1α axis on apoptosis of oral squamous cell carcinoma cells by modulation of mitochondrial apoptosis pathway [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 348-358. |
| [5] | Xiao LIU,Fei FEI,Tao LIU,Lan QIN. Relationship between serum PI3K and Akt levels and thrombocytopenia in patients with Sjögren’s syndrome and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 483-490. |
| [6] | Yaping LI,Chunyan TAN,Lujie ZHAO,Jiayi ZHAO,Ting LI,Xiao YANG,Xiaoyun YANG. Inductive effect of lysophosphatidic acid combined with 6-hydroxydopamine on apoptosis of SH-SY5Y cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 152-161. |
| [7] | Jiaxin WANG,Junwen MAO,Xuan ZHANG. Expression of natural autoantibodies against apoptosis inhibitory genes in plasma of patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 228-235. |
| [8] | Huaimin LIANG,Jiacheng JIN,Wenhua CHEN,Yuyao LI,Hangyu WANG,Ke ZHANG,Jinhui WANG. UPLC-Q-TOF/MS and network pharmacology analysis and experimental verification based on potential active ingredients and mechanisms of medicinal Mulberry Leaves in anti-acute kidney injury [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 56-69. |
| [9] | Shanshan SUN,Mei LU,Xinfu GAO,LYu Guangyao,Baolei Zhao,LYu Wenwen. Inhibitory effect of Bradykinin 1 receptor antagonist ELN441958 on proliferation of HepG2 cells by regulating Akt/FoxO3a signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 70-80. |
| [10] | Xiaohan YAO,Mingchen YAO,Zhiqing WANG,Heyang LI,Yan YAN,Ningjing LEI. Effect of silencing GPR139 gene on proliferation, apoptosis and autophagy of breast cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 1-9. |
| [11] | Bing BAI,Qian ZHANG,Tao PU,Yu NI,Tingting HU,Linhong HU,Yibin YANG. Effect of angiopoietin 1 and tyrosine kinase receptor 2 inhibitor on glucose transportation in endothelial cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1487-1497. |
| [12] | Haidong ZHU,Changkun LYU,Wei SHI. Effect of berberine hydrochloride on autophagy of HeLa cells infected with herpes simplex virus type 1 by regulating PI3K/AKT/mTOR signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1607-1617. |
| [13] | Han XUE,Yuxin FAN,Ting ZHANG,Zhimin LI,Mingge HUO,Xingang GUAN. Preparation of nanodrug PTX2 NPs and its killing effect on human lung cancer A549 cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1260-1266. |
| [14] | Xun LU,Chengxin MA,Jianan YANG,Xinxin GUO,Xiaobei XIE,Binghai ZHAO,Hongzhi LI. Research progress in mechanism of podocyte injury and its potential therapeutic strategies for diabetic nephropathy [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1415-1422. |
| [15] | Jiarui LI,Zhenlin YANG,Fan GAO,Jingjing GUO,Jinzi LI. Effect of miR-34a-5p on hippocampal neuron apoptosis in rats with temporal lobe epilepsy and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 939-947. |
|